...
首页> 外文期刊>Dermatologic surgery >Dual-Frequency Ultrasound as a New Treatment Modality for Refractory Rosacea: A Retrospective Study.
【24h】

Dual-Frequency Ultrasound as a New Treatment Modality for Refractory Rosacea: A Retrospective Study.

机译:双频超声作为难治性Rosacea的新治疗方式:回顾性研究。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Dual-frequency ultrasound (DFU) has emerged as a new treatment modality for improving inflammatory skin disorders. Although there have been few pilot studies, there are a limited number of studies that investigated efficacy of DFU on refractory rosacea. This study investigated the effect of DFU on patients with refractory rosacea. The authors retrospectively analyzed medical records of 42 patients with refractory rosacea (erythematotelangiectatic rosacea [ETR], n = 26; papulopustular rosacea [PPR], n = 14, mixed, n = 2). The patients were treated with DFU twice per week for the 1st week, and then once per week thereafter. Efficacy was assessed using erythema index (EI), transepithelial water loss (TEWL), and patient self-assessment (PSA). Treatment with DFU resulted in significant decrease in EI, TEWL, and PSA. No significant difference was noted between ETR and PPR. Application of DFU in patients with refractory rosacea resulted in improvement in persistent erythema, barrier dysfunction, and patient-reported symptoms. Dual-frequency ultrasound may be an additional treatment option for rosacea that is resistant to other treatments.
机译:双频超声(DFU)已成为改善炎症皮肤病的新治疗方式。虽然有很少的试点研究,但有一个有限数量的研究,即研究了DFU对难治性Rosacea的疗效。本研究调查了DFU对耐火难治患者的影响。作者回顾性地分析了42例难治性Rosacea患者的医学记录(红斑石术术术术患者,N = 26;烟灰术rosacea,n = 14,混合,n = 2)。患者每周两次用DFU处理,然后每周两次,然后每周一次。使用红斑指数(EI),TRANSEPITHELIAL DURDIES(TEWL)和患者自我评估(PSA)评估疗效。用DFU治疗导致EI,TEWL和PSA显着降低。在ETR和PPR之间没有发现显着差异。 DFU在难治性Rosacea患者中的应用导致持续性红斑,屏障功能障碍和患者报告的症状改善。双频超声可以是用于耐用其他处理的Rosacea的额外处理选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号